Biofilm switch and immune response determinants at early stages of infection
dc.contributor.author | Valle Turrillas, Jaione | |
dc.contributor.author | Solano Goñi, Cristina | |
dc.contributor.author | García Martínez, Begoña | |
dc.contributor.author | Toledo Arana, Alejandro | |
dc.contributor.author | Lasa Uzcudun, Íñigo | |
dc.contributor.department | IdAB. Instituto de Agrobiotecnología / Agrobioteknologiako Institutua | es_ES |
dc.contributor.funder | Gobierno de Navarra / Nafarroako Gobernua: IIQ14066.RI1 | es |
dc.contributor.funder | Gobierno de Navarra / Nafarroako Gobernua: IIM13329.RI1 | es |
dc.contributor.funder | Gobierno de Navarra / Nafarroako Gobernua: 1312/2010 | es |
dc.date.accessioned | 2016-11-04T15:28:56Z | |
dc.date.available | 2016-11-04T15:28:56Z | |
dc.date.issued | 2013 | |
dc.description.abstract | Biofilm development is recognized as a major virulence factor underlying most chronic bacterial infections. When a biofilm community is established, planktonic cells growing in the surroundings of a tissue switch to a sessile lifestyle and start producing a biofilm matrix. The initial steps of in vivo biofilm development are poorly characterized and difficult to assess experimentally. A great amount of in vitro evidence has shown that accumulation of high levels of cyclic dinucleotides (c-di-NMPs) is the most prevalent hallmark governing the initiation of biofilm development by bacteria. As mentioned above, recent studies also link detection of c-di-NMPs by host cells with the activation of a type I interferon immune response against bacterial infections. We discuss here c-di-NMP signaling and the host immune response in the context of the initial steps of in vivo biofilm development. | en |
dc.description.sponsorship | J. Valle was supported by Spanish Ministry of Science and Innovation ‘Ramón y Cajal’ contract. Work in the Laboratory of Microbial Biofilms is funded by the Spanish Ministry of Economy and Competitiveness grants BIO2011-30503-C02-02, AGL2011-23954, and BFU2011-23222, as well as by ERA-NET Pathogenomics (PIM2010EPA-00606) and grants from the Departamento de Innovación (IIQ14066.RI1 and IIM13329.RI1) and Departamento de Salud (Resolución 1312/2010), Gobierno de Navarra. | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | 10.1016/j.tim.2013.05.008 | |
dc.identifier.issn | 0966-842X (Print) | |
dc.identifier.issn | 1878-4380 (Electronic) | |
dc.identifier.uri | https://academica-e.unavarra.es/handle/2454/22576 | |
dc.language.iso | eng | en |
dc.publisher | Elsevier (Cell Press) | en |
dc.relation.ispartof | Trends in Microbiology, August 2013, Vol. 21, No. 8 | en |
dc.relation.projectID | info:eu-repo/grantAgreement/MICINN//BIO2011-30503-C02-02/ES/ | |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/6PN/AGL2011-23954/ | |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/6PN/BFU2011-23222/ | |
dc.relation.publisherversion | https://dx.doi.org/10.1016/j.tim.2013.05.008 | |
dc.rights | © 2013 Elsevier Ltd. All rights reserved. | en |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
dc.subject | Biofilms | en |
dc.subject | Chronic infections | en |
dc.subject | Innate immune response | en |
dc.subject | c-di-GMP | en |
dc.subject | STING | en |
dc.subject | PAMPs | en |
dc.subject | Type I interferon | en |
dc.subject | cGAS | en |
dc.title | Biofilm switch and immune response determinants at early stages of infection | en |
dc.type | info:eu-repo/semantics/article | |
dc.type.version | info:eu-repo/semantics/acceptedVersion | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 022e51f1-528f-49d1-901a-5a76313639df | |
relation.isAuthorOfPublication | b6a392a0-c0e5-4c6f-9086-6fa4291d0856 | |
relation.isAuthorOfPublication | 7f89244d-67ab-4c4d-b868-ad7ae9112055 | |
relation.isAuthorOfPublication | 777af947-83d1-4cb7-b485-b0430d3e28be | |
relation.isAuthorOfPublication | c654d104-1ae2-41cf-9215-4b4bed3e5ea6 | |
relation.isAuthorOfPublication.latestForDiscovery | 022e51f1-528f-49d1-901a-5a76313639df |